Abstract
Introduction Functional Neurological Disorder (FND) is a common cause of referral to neurology services. FND has been shown to lead to significant healthcare resource use, and is associated with significant disability, comorbidity, and distress. This leads to substantial direct, indirect, and intangible costs to the patient and society.
Methods We recruited consecutive patients with FND referred to a tertiary FND specialist clinic. We assessed health and social care resource use, in the 6 months preceding their consultation through a modified version of the Client Service Receipt Inventory (CSRI) in the form of a postal questionnaire. The total cost was estimated by combining the number and frequency of health resource use with standard national unit costs. We also assessed indirect costs such as informal care and loss of income.
Results We collected data on 118 subjects. Patients with comorbid anxiety or depression had higher costs in the preceding 6 months, as did patients who had a longer duration of FND symptoms. Indirect costs were larger than the already substantial direct costs, and a large proportion of FND patients were receiving government support.
Conclusion This study highlights the high cost of FND to both patients and health systems. Adequate reform of the patient pathway and re-organization of services to make diagnoses, and initiate treatment more quickly, would likely reduce these costs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
M Yogarajah is funded by an MRC CARP award (MR/V037676/1). For the purpose of open access, the corresponding author has applied a Creative Commons Attribution (CC BY) license to any Author Accepted Manuscript version arising. MY carries out independent expert medicolegal work including in relation to FND M.J. Edwards provides expert evidence and clinical treatment in medicolegal settings. He receives royalties from the Oxford University Press for The Oxford Specialist Handbook of Parkinsons Disease and Other Movement Disorders. In the past year he has received honoraria for education work for Merz Pharma G Nielsen receives research funding from the National Institute for Health and Care Research R Hunter has received funding from the National Institute for Health Research
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of the clinical governance and audit office at St Georges Hospital gaven ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Co-first author
Statements and Declarations MY is funded by an MRC CARP award (MR/V037676/1). For the purpose of open access, the corresponding author has applied a Creative Commons Attribution (CC BY) license to any Author Accepted Manuscript version arising
Data Availability
All data produced in the present study are available upon reasonable request to the authors
